I think the key here is does who has enough votes to pass/reject the scheme implementation??
For the scheme to be approved, a resolution in favour must be passed at the scheme meeting by each class of target shareholders by both: 75% of the votes cast on the resolution; and. more than 50% in number of the target shareholders voting on the resolution (in person or by proxy)
Ann: Proposed Acquisition of ResApp Health by Pfizer, page-107
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
